Brief: Touyun Biotech Group Says HY Loss Attributable HK$88.1 Mln
26/08/2022 13:50
Aug 26 (Reuters) - Touyun Biotech Group Ltd 1332.HK :
* HY LOSS ATTRIBUTABLE HK$88.1 MILLION VERSUS LOSS HK$61.4
MILLION
* HY REVENUE FROM SALES OF GOODS AND SERVICES RENDERED
HK$166.1
MILLION VERSUS HK$139.2 MILLION
Source text for Eikon: ID:nHKS7PN8Dt
Further company coverage: 1332.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Touyun Biotech
See all newsHong Kong's Touyun Biotech profit surges on fair value gains
Brief: Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026
Brief: Touyun Biotech To Issue 123 Million New Shares At Hk$0.122 Per Share
Brief: Touyun Biotech Appoints Zhou Ruijuan As Executive Director And Vice Chairlady
Brief: Touyun Biotech Group Posts FY Revenue HKD 67 Million